Sin-Itiro Tomonaga fue un científico cuya obra permitió poner orden en una de las teorías más complejas y desconcertantes jamás formuladas: la electrodinámica cuántica. Un talento que emergió en tiempos difíciles Nacido …
Sin-Itiro Tomonaga: el físico que ayudó a domesticar el caos cuántico Read More »
The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people think.
Biotechs Must Face Reality To Succeed in Today’s Funding Environment Read More »
If the U.S. can help Japan reform its drug pricing controls, both countries stand to benefit.
Japan’s Drug Prices Are Creating Problems for Washington and Tokyo Alike Read More »
The rule standardizes the electronic exchange of medical records and other documents requested by payers to support claims. It should cut out outdated methods like faxes and snail mail, the CMS said.
CMS sets standards for electronic transfer of claims documentation Read More »
The task force will share resources and coordinate enforcement across the Federal Trade Commission’s disparate bureaus to better address consumer protection and competition issues in healthcare, the FTC commissioner said.
Es sorprendente lo mucho que una comunicación deficiente entre departamentos, sumada a los errores a mano y el caos en el inventario, puede frenar el avance de una empresa. De manera cotidiana, quienes lideran compañías sienten esa presión constante por mantener el orden, …
Cómo un ERP optimiza la gestión de producción y comercial en tu empresa Read More »
Healthcare investor Kevin Tang and his allies now hold almost every leadership position at Aurinia Pharmaceuticals, the company at the heart of former CDER Director George Tidmarsh’s exit from the FDA.
Tang Seizes Control of Aurinia, Taking CEO Post in Total Transformation of C-Suite Read More »
The task force will share resources and coordinate enforcement across the Federal Trade Commission’s disparate bureaus to better address consumer protection and competition issues in healthcare, the FTC commissioner said.
The deal, which will see Labcorp run 12 patient service centers, is part of the company’s ongoing efforts to expand through acquisitions.
Labcorp closes purchase of New York pathology reference lab assets Read More »
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne disease in a Phase 3 trial—but failed to hit a predetermined confidence interval.
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint Read More »
